The effect of barium on [3H]noradrenalin release from the human neuroblastoma SH-SY5Y

Eur J Neurosci. 1995 May 1;7(5):875-80. doi: 10.1111/j.1460-9568.1995.tb01074.x.

Abstract

Replacement of Ca2+ with Ba2+ in HEPES-buffered saline stimulated [3H]noradrenalin release in the human neuroblastoma clone SH-SY5Y by up to 20% of the cell content in the absence of other secretory stimuli. The Ba(2+)-evoked release was inhibited by 85% by 3 microM tetrodotoxin and 95% by 5 microM nifedipine. Ba2+ also increased the potency of K(+)-evoked release of [3H]noradrenalin, as maximal release was observed with 60 mM K+ compared with the 100 mM K+ necessary to achieve maximal release in the presence of Ca2+. In contrast, replacing Ca2+ with Ba2+ had little effect on carbachol- and bradykinin-evoked release of [3H]noradrenalin. No evidence was obtained from studies on changes in [Ca2+]i (in response to 100 microM carbachol) using fura-2 that Ba2+ could enter intracellular stores in SH-SY5Y cells. Whole-cell patch-clamp studies showed that Ba2+ depolarizes SH-SY5Y cells as well as enhancing inward Ca2+ channel currents and shifting their voltage dependence to more negative values. These results are discussed in terms of the hypothesis that Ba2+ blocks K+ channels, leading to depolarization followed by opening of voltage-sensitive Na+ channels. This in turn opens voltage-sensitive L-type Ca2+ channels, which are coupled to the release of [3H]noradrenalin in SH-SY5Y cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Barium / pharmacology*
  • Calcium / metabolism
  • Carbachol / pharmacology
  • Evoked Potentials / drug effects
  • Exocytosis
  • Humans
  • Neuroblastoma
  • Neurons / metabolism*
  • Nifedipine / pharmacology
  • Norepinephrine / metabolism*
  • Patch-Clamp Techniques
  • Potassium / pharmacology
  • Tetrodotoxin / pharmacology

Substances

  • Barium
  • Tetrodotoxin
  • Carbachol
  • Nifedipine
  • Potassium
  • Calcium
  • Norepinephrine